Challenge your understanding of motor fluctuation management in advanced PD. Explore continuous drug delivery pharmacology, pivotal trial outcomes, and patient selection for subcutaneous infusion.

Test your expertise on IgG autoantibody-driven neuromuscular disease. Explore FcRn biology, IgG reduction mechanisms, landmark trial data, and expanding indications in antibody-mediated disease.

Test your knowledge on SMA pathogenesis, SMN protein biology, and the clinical impact of antisense oligonucleotide therapy. Explore presymptomatic treatment outcomes, real-world data, and the evolving SMA treatment algorithm.

Deepen your understanding of lymphocyte trafficking blockade in RRMS. Challenge your knowledge on alpha-4-integrin biology, PML risk stratification, extended interval dosing strategies, and 2025 multicenter real-world evidence.

Test your clinical expertise in COPD pharmacotherapy. Explore LAMA/LABA synergy, pivotal trial and real-world outcomes, patient selection, and quality-of-life endpoints.

Test your expertise in CIDP pathophysiology, humoral IgG-mediated immune mechanisms, and FcRn-targeted therapeutics. Explore the ADHERE Phase 3 trial, patient selection, response assessment, and self-administration.

Explore the neurobiology and clinical management of agitation in Alzheimer's dementia. Test your knowledge on approved pharmacotherapy mechanisms, landmark trial outcomes, long-term durability, and caregiver impact.

ATTR amyloidosis often presents with multisystem manifestations years before diagnosis. Test your knowledge of key red flags, common mimicking conditions, and clinical patterns that may support earlier recognition.

Test your knowledge of communication gaps among ICU clinicians, patients, and caregivers, including PICS awareness, shared decision-making, and patient-centered care.

Test your knowledge of physician-scientist contributions, NIH funding trends, team science strategies, and training pathways shaping the future of academic medicine.

Test your clinical knowledge of Alzheimer’s and Parkinson’s disease biology, early symptom recognition, and the emerging role of AI-assisted neuroimaging in diagnosis and disease management.